Ari Mahrer

Apr 9, 2024 | bizjournals.com | Ari Mahrer |Joanne Drilling

Missouri added 2,980 tax filers earning $1 million or more between 2020 and 2021, while Illinois added 9,370. That’s according to new data from the Internal Revenue Service that breaks down the number of million-dollar filers based on adjusted gross income. The data includes single filers, married couples filing jointly and households.

Apr 5, 2024 | bizjournals.com | Ari Mahrer |Joanne Drilling

California added 46,540 tax filers earning $1 million or more between 2020 and 2021. That’s according to new data from the Internal Revenue Service that breaks down the number of million-dollar filers based on adjusted gross income. The data includes single filers, married couples filing jointly and households.

Mar 25, 2024 | bizjournals.com | Ari Mahrer

Venture capital funding to the life sciences sector has returned to prepandemic levels after a boom that ran from 2020 to mid-2022, but the San Francisco Bay Area remains a national hot spot. According to a report by Cushman & Wakefield, the region secured over $6.67 billion in 2023. That’s a roughly 40% decrease from 2022 but still accounts for 26% of total U.S. life sciences funding, the second largest behind Boston. There were 235 deals total with an average deal size of $28.37 million.

Mar 20, 2024 | bizjournals.com | Ari Mahrer

Brands: you can love ‘em or hate ‘em, but in the end we all know ‘em. That recognition is what companies count on to build their brands’ success. But familiarity alone doesn’t equal high value. A brand’s value refers to the value of earnings related to its reputation. There are varying methodologies to determine this, but all are led by one guiding question: What do people actually pay for this brand?

Mar 14, 2024 | bizjournals.com | Ari Mahrer

Venture capital funding to the life sciences sector has returned to prepandemic levels after a boom that ran from 2020 to mid-2022, but the Bay Area remains a national hot spot. According to a report by Cushman & Wakefield, the region secured over $6.67 billion in 2023. That’s a roughly 40% decrease from 2022 but still accounts for 26% of total U.S. life sciences funding, the second largest behind Boston. There were 235 deals total with an average deal size of $28.37 million.